Mercury Pharmaceuticals is a dynamic and entrepreneurial team. We are inspired by the passionate commitment to make a positive difference in the lives of patients.
Current open positions:
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
16
Mar 2026
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
16
Mar 2026
One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found.
15
Mar 2026
A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment outcomes. The authors conclude that microbiome changes seen during therapy are most likely driven by diet, behavior, and weight loss, although microbial profiling may eventually help predict patient responses.
15
Mar 2026
Analysis of the 2023–2024 National Health Interview Survey shows that 18.8% of U.S. adults use tobacco, while cigarette smoking has fallen to 9.9%, the first time it has dropped below 10% nationally. Despite this milestone, millions of Americans still use cigars, e-cigarettes, or smokeless tobacco, with notable disparities across age, income, occupation, and geography.